Literature DB >> 25481308

Collagen density regulates xenobiotic and hypoxic response of mammary epithelial cells.

Colleen S Curran1, Esteban R Carrillo2, Suzanne M Ponik3, Patricia J Keely4.   

Abstract

Breast density, where collagen I is the dominant component, is a significant breast cancer risk factor. Cell surface integrins interact with collagen, activate focal adhesion kinase (FAK), and downstream cell signals associated with xenobiotics (AhR, ARNT) and hypoxia (HIF-1α, ARNT). We examined if mammary cells cultured in high density (HD) or low density (LD) collagen gels affected xenobiotic or hypoxic responses. ARNT production was significantly reduced by HD culture and in response to a FAK inhibitor. Consistent with a decrease in ARNT, AhR and HIF-1α reporter activation and VEGF production was lower in HD compared to LD. However, P450 production was enhanced in HD and induced by AhR and HIF-1α agonists, possibly in response to increased NF-κB activaton. Thus, collagen density differentially regulates downstream cell signals of AhR and HIF-1α by modulating the activity of FAK, the release of NF-κB transcriptional factors, and the levels of ARNT.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast density; Collagen; Focal adhesion kinase (FAK); Hypoxia; Xenobiotics

Mesh:

Substances:

Year:  2014        PMID: 25481308      PMCID: PMC4323890          DOI: 10.1016/j.etap.2014.10.017

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  63 in total

1.  Growth factors and stromal matrix proteins associated with mammographic densities.

Authors:  Y P Guo; L J Martin; W Hanna; D Banerjee; N Miller; E Fishell; R Khokha; N F Boyd
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-03       Impact factor: 4.254

Review 2.  Metabolic implication of tumor:stroma crosstalk in breast cancer.

Authors:  Andrea Morandi; Paola Chiarugi
Journal:  J Mol Med (Berl)       Date:  2014-01-24       Impact factor: 4.599

3.  Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer.

Authors:  Amanda I Phipps; Diana S M Buist; Kathleen E Malone; William E Barlow; Peggy L Porter; Karla Kerlikowske; Ellen S O'Meara; Christopher I Li
Journal:  Ann Epidemiol       Date:  2012-02-25       Impact factor: 3.797

4.  Association of ARNT splice variants with estrogen receptor-negative breast cancer, poor induction of vascular endothelial growth factor under hypoxia, and poor prognosis.

Authors:  C Qin; C Wilson; C Blancher; M Taylor; S Safe; A L Harris
Journal:  Clin Cancer Res       Date:  2001-04       Impact factor: 12.531

5.  Suspension-mediated induction of Hepa 1c1c7 Cyp1a-1 expression is dependent on the Ah receptor signal transduction pathway.

Authors:  C M Sadek; B L Allen-Hoffmann
Journal:  J Biol Chem       Date:  1994-12-16       Impact factor: 5.157

6.  The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue.

Authors:  M Iscan; T Klaavuniemi; T Coban; N Kapucuoglu; O Pelkonen; H Raunio
Journal:  Breast Cancer Res Treat       Date:  2001-11       Impact factor: 4.872

7.  Microtubules-interfering agents restrict aryl hydrocarbon receptor-mediated CYP1A2 induction in primary cultures of human hepatocytes via c-jun-N-terminal kinase and glucocorticoid receptor.

Authors:  Radim Vrzal; Martine Daujat-Chavanieu; Jean-Marc Pascussi; Jitka Ulrichova; Patrick Maurel; Zdenek Dvorak
Journal:  Eur J Pharmacol       Date:  2007-12-03       Impact factor: 4.432

8.  Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line.

Authors:  Gennifer D Goode; Billy R Ballard; H Charles Manning; Michael L Freeman; Yibin Kang; Sakina E Eltom
Journal:  Int J Cancer       Date:  2013-07-05       Impact factor: 7.396

9.  SU5416, a VEGF receptor inhibitor and ligand of the AHR, represents a new alternative for immunomodulation.

Authors:  Joshua D Mezrich; Linh P Nguyen; Greg Kennedy; Manabu Nukaya; John H Fechner; Xiaoji Zhang; Yongna Xing; Christopher A Bradfield
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

Review 10.  Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.

Authors:  Vasilis P Androutsopoulos; Aristidis M Tsatsakis; Demetrios A Spandidos
Journal:  BMC Cancer       Date:  2009-06-16       Impact factor: 4.430

View more
  2 in total

1.  COL8A1 facilitates the growth of triple-negative breast cancer via FAK/Src activation.

Authors:  Fumiaki Sato; Atsunobu Sagara; Kaede Tajima; Shotaro Miura; Kenjiro Inaba; Yusuke Ando; Teruaki Oku; Takashi Murakami; Yoshinori Kato; Tetsuro Yumoto
Journal:  Breast Cancer Res Treat       Date:  2022-05-28       Impact factor: 4.872

Review 2.  Review of quantitative multiscale imaging of breast cancer.

Authors:  Michael A Pinkert; Lonie R Salkowski; Patricia J Keely; Timothy J Hall; Walter F Block; Kevin W Eliceiri
Journal:  J Med Imaging (Bellingham)       Date:  2018-01-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.